Orphanet Journal of Rare Diseases (Apr 2023)

Transition for adolescents with a rare disease: results of a nationwide German project

  • Corinna Grasemann,
  • Jakob Höppner,
  • Peter Burgard,
  • Michael M. Schündeln,
  • Nora Matar,
  • Gabriele Müller,
  • Heiko Krude,
  • Reinhard Berner,
  • Min Ae Lee-Kirsch,
  • Fabian Hauck,
  • Kerstin Wainwright,
  • Sylvana Baumgarten,
  • Janet Atinga,
  • Jens J. Bauer,
  • Eva Manka,
  • Julia Körholz,
  • Cordula Kiewert,
  • André Heinen,
  • Tanita Kretschmer,
  • Tobias Kurth,
  • Janna Mittnacht,
  • Christoph Schramm,
  • Christoph Klein,
  • Holm Graessner,
  • Olaf Hiort,
  • Ania C. Muntau,
  • Annette Grüters,
  • Georg F. Hoffmann,
  • Daniela Choukair

DOI
https://doi.org/10.1186/s13023-023-02698-2
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Purpose The transition process from paediatric/adolescent to adult medical care settings is of utmost importance for the future health of adolescents with chronic diseases and poses even more difficulties in the context of rare diseases (RDs). Paediatric care teams are challenged to deliver adolescent-appropriate information and structures. Here we present a structured transition pathway which is patient-focused and adoptable for different RDs. Methods The transition pathway for adolescents 16 years and older was developed and implemented as part of a multi-centre study in 10 university hospitals in Germany. Key elements of the pathway included: assessment of patients’ disease-related knowledge and needs, training/educational and counselling sessions, a structured epicrisis and a transfer appointment jointly with the paediatric and adult specialist. Specific care coordinators from the participating university hospitals were in charge of organization and coordination of the transition process. Results Of a total of 292 patients, 286 completed the pathway. Deficits in disease-specific knowledge were present in more than 90% of participants. A need for genetic or socio-legal counselling was indicated by > 60%. A mean of 2.1 training sessions per patient were provided over a period of almost 1 year, followed by the transfer to adult care in 267 cases. Twelve patients remained in paediatric care as no adult health care specialist could be identified. Targeted training and counselling resulted in improved disease-specific knowledge and contributed to empowering of patients. Conclusion The described transition pathway succeeds to improve health literacy in adolescents with RDs and can be implemented by paediatric care teams in any RD specialty. Patient empowerment was mainly achieved by individualized training and counselling.

Keywords